TITAN BIOTECH LTD.

	2019 ( ₹ in Cr. )	2018 ( ₹ in Cr. )	2017 ( ₹ in Cr. )	2016 ( ₹ in Cr. )	2015 ( ₹ in Cr. )
INCOME :
Sales Turnover	64.91	58.19	52.74	48.9	42.41
Other Income	0.69	0.45	0.28	0.55	0.4
Stock Adjustments	3.85	-1.19	1.6	0.4	1.29
Total Income	69.45	57.45	54.62	49.85	44.1
EXPENDITURE :
Raw Materials	36.55	30.58	35.8	34.35	31.38
Excise Duty	0	0.82	0	3.13	2.1
Power and Fuel Cost	3.25	3.19	2.09	0.07	0.06
Other Manufacturing Expenses	0.74	0.69	4.13	0.4	0.13
Employee Cost	9.43	6.61	2.89	3.45	2.73
Selling and Administration Expenses	9.4	7.85	3.87	3.77	3.21
Miscellaneous Expenses	0.49	0.28	0.19	0.22	0.21
Less: Preoperative Expenditure Capitalised	0	0	0	0	0
Profit before Interest, Depreciation and Tax	9.6	7.42	5.64	4.45	4.28
Interest and Financial Charges	2.34	2.39	1.48	1.03	0.99
Profit before Depreciation and Tax	7.26	5.03	4.16	3.42	3.29
Depreciation	1.71	0.93	0.82	0.77	0.84
Minority Interest before PAT	0	0	0	0	0
Profit Before Tax	5.55	4.11	3.35	2.66	2.45
Tax	1.64	1.44	1.17	0.89	0.82
Profit After Tax	3.91	2.67	2.18	1.77	1.63
Minority Interest after PAT	0.39	0.12	0	0	0
Profit/Loss of Associate Company	0	0	0	0	0
Profit after Minority Interest and P/L of Assoc. Co.	3.52	2.54	2.18	1.77	1.63
Adjustment below Net Profit	0	0	0	0	0
P and L Balance brought forward	11.6	9.76	8.79	7.72	6.8
Appropriations	0	0.7	0.7	0.7	0.7
P and L Bal. carried down	15.13	11.6	10.27	8.79	7.73
Equity Dividend	0	0.7	0.7	0.7	0.7
Preference Dividend	0	0	0	0	0
Corporate Dividend Tax	0	0	0	0	0
Equity Dividend (%)	0	7.5	7.5	7.5	7.5
Earning Per Share (Rs.)	4.26	3.29	2.82	2.28	2.11
Book Value	38.94	31.47	29.74	27.82	26.46
Extraordinary Items	-0.05	0	0	0	0

2019 ( ₹ in Cr. )

2018 ( ₹ in Cr. )

2017 ( ₹ in Cr. )

2016 ( ₹ in Cr. )

2015 ( ₹ in Cr. )

INCOME :

Sales Turnover

64.91

58.19

52.74

48.9

42.41

Other Income

0.69

0.45

0.28

0.55

0.4

Stock Adjustments

3.85

-1.19

1.6

0.4

1.29

Total Income

69.45

57.45

54.62

49.85

44.1

EXPENDITURE :

Raw Materials

36.55

30.58

35.8

34.35

31.38

Excise Duty

0.82

3.13

2.1

Power and Fuel Cost

3.25

3.19

2.09

0.07

0.06

Other Manufacturing Expenses

0.74

0.69

4.13

0.4

0.13

Employee Cost

9.43

6.61

2.89

3.45

2.73

Selling and Administration Expenses

9.4

7.85

3.87

3.77

3.21

Miscellaneous Expenses

0.49

0.28

0.19

0.22

0.21

Less: Preoperative Expenditure Capitalised

Profit before Interest, Depreciation and Tax

9.6

7.42

5.64

4.45

4.28

Interest and Financial Charges

2.34

2.39

1.48

1.03

0.99

Profit before Depreciation and Tax

7.26

5.03

4.16

3.42

3.29

Depreciation

1.71

0.93

0.82

0.77

0.84

Minority Interest before PAT

Profit Before Tax

5.55

4.11

3.35

2.66

2.45

Tax

1.64

1.44

1.17

0.89

0.82

Profit After Tax

3.91

2.67

2.18

1.77

1.63

Minority Interest after PAT

0.39

0.12

Profit/Loss of Associate Company

Profit after Minority Interest and P/L of Assoc. Co.

3.52

2.54

2.18

1.77

1.63

Adjustment below Net Profit

P and L Balance brought forward

11.6

9.76

8.79

7.72

6.8

Appropriations

0.7

P and L Bal. carried down

15.13

11.6

10.27

8.79

7.73

Equity Dividend

0.7

Preference Dividend

Corporate Dividend Tax

Equity Dividend (%)

7.5

Earning Per Share (Rs.)

4.26

3.29

2.82

2.28

2.11

Book Value

38.94

31.47

29.74

27.82

26.46

Extraordinary Items

-0.05

	2019 ( ₹ in Cr. )	2018 ( ₹ in Cr. )	2017 ( ₹ in Cr. )	2016 ( ₹ in Cr. )	2015 ( ₹ in Cr. )
SOURCES OF FUNDS :
Share Capital	8.26	7.74	7.74	7.74	7.74
Reserves and Surplus	23.91	16.62	15.27	13.79	12.73
Total Shareholders Funds	32.17	24.36	23.01	21.53	20.47
Secured Loans	3.22	3.98	3.62	7.46	6.11
Unsecured Loans	21.41	23.42	18.84	3.95	1.6
Total Debt	24.63	27.4	22.46	11.41	7.71
Minority Interest	1.58	1.19	1.13	1.13	0
Total Liabilities	58.38	52.95	46.6	34.07	28.18
APPLICATION OF FUNDS :
Gross Block	36.9	21.74	19.98	17.58	16.37
Less: Accum. Depreciation	7.89	8.06	7.13	6.32	5.54
Net Block	29.01	13.68	12.85	11.26	10.83
Capital Work in Progress	0	13.31	9.32	4.55	1.14
Investments	0	0	0	0	0.05
Current Assets, Loans and Advances
Inventories	21.13	17.58	14.5	10.99	11.07
Sundry Debtors	9.24	7.77	6.34	5.92	6.41
Cash and Bank Balance	2.04	1.24	4.3	3.56	0.36
Loans and Advances	3.68	3.48	4.88	3.77	3.65
Less: Current Liab. and Prov.
Current Liabilities	6.55	4.13	3.88	4.51	3.9
Provisions	0.18	0	1.71	1.48	1.42
Net Current Assets	29.36	25.94	24.43	18.25	16.17
Miscellaneous Expenses not w/o	0	0	0	0	0
Total Assets	58.37	52.93	46.6	34.06	28.19
Contingent Liabilities	0	0	0	0	0

2019 ( ₹ in Cr. )

2018 ( ₹ in Cr. )

2017 ( ₹ in Cr. )

2016 ( ₹ in Cr. )

2015 ( ₹ in Cr. )

SOURCES OF FUNDS :

Share Capital

8.26

7.74

Reserves and Surplus

23.91

16.62

15.27

13.79

12.73

Total Shareholders Funds

32.17

24.36

23.01

21.53

20.47

Secured Loans

3.22

3.98

3.62

7.46

6.11

Unsecured Loans

21.41

23.42

18.84

3.95

1.6

Total Debt

24.63

27.4

22.46

11.41

7.71

Minority Interest

1.58

1.19

1.13

Total Liabilities

58.38

52.95

46.6

34.07

28.18

APPLICATION OF FUNDS :

Gross Block

36.9

21.74

19.98

17.58

16.37

Less: Accum. Depreciation

7.89

8.06

7.13

6.32

5.54

Net Block

29.01

13.68

12.85

11.26

10.83

Capital Work in Progress

13.31

9.32

4.55

1.14

Investments

0.05

Current Assets, Loans and Advances

Inventories

21.13

17.58

14.5

10.99

11.07

Sundry Debtors

9.24

7.77

6.34

5.92

6.41

Cash and Bank Balance

2.04

1.24

4.3

3.56

0.36

Loans and Advances

3.68

3.48

4.88

3.77

3.65

Less: Current Liab. and Prov.

Current Liabilities

6.55

4.13

3.88

4.51

3.9

Provisions

0.18

1.71

1.48

1.42

Net Current Assets

29.36

25.94

24.43

18.25

16.17

Miscellaneous Expenses not w/o

Total Assets

58.37

52.93

46.6

34.06

28.19

Contingent Liabilities

TITAN BIOTECH LTD.

Enjoy Lifetime Free Delivery Trade